Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9062 |
High Similarity |
NPD3027 |
Phase 3 |
0.8571 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD1613 |
Approved |
0.8271 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8195 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8145 |
Intermediate Similarity |
NPD228 |
Approved |
0.8031 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7891 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7883 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7794 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7761 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7682 |
Intermediate Similarity |
NPD1934 |
Approved |
0.768 |
Intermediate Similarity |
NPD290 |
Approved |
0.7632 |
Intermediate Similarity |
NPD2801 |
Approved |
0.763 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7612 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7609 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7597 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7556 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7554 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7536 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7519 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7519 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7518 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7481 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.748 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7466 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7445 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7444 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7422 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7421 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD940 |
Approved |
0.7419 |
Intermediate Similarity |
NPD846 |
Approved |
0.7407 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7357 |
Intermediate Similarity |
NPD600 |
Approved |
0.7357 |
Intermediate Similarity |
NPD596 |
Approved |
0.7353 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7346 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD37 |
Approved |
0.7325 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD839 |
Approved |
0.7324 |
Intermediate Similarity |
NPD840 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7287 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7287 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7284 |
Intermediate Similarity |
NPD7054 |
Approved |
0.728 |
Intermediate Similarity |
NPD291 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7472 |
Approved |
0.723 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7213 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7211 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7211 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7211 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7203 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD289 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7188 |
Intermediate Similarity |
NPD968 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7172 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7153 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7114 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7103 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7101 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7097 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD1512 |
Approved |
0.705 |
Intermediate Similarity |
NPD2232 |
Approved |
0.705 |
Intermediate Similarity |
NPD2233 |
Approved |
0.705 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7034 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7032 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7025 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD6190 |
Approved |
0.702 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7019 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7016 |
Intermediate Similarity |
NPD844 |
Approved |
0.7014 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7014 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7007 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7007 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD4675 |
Approved |
0.6987 |
Remote Similarity |
NPD4678 |
Approved |
0.6986 |
Remote Similarity |
NPD447 |
Suspended |
0.6985 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.698 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6975 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6974 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD2978 |
Approved |
0.6962 |
Remote Similarity |
NPD2977 |
Approved |
0.6957 |
Remote Similarity |
NPD9381 |
Approved |
0.6957 |
Remote Similarity |
NPD9384 |
Approved |
0.6957 |
Remote Similarity |
NPD4626 |
Approved |
0.6957 |
Remote Similarity |
NPD5494 |
Approved |
0.6954 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD7473 |
Discontinued |
0.695 |
Remote Similarity |
NPD2922 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD52 |
Approved |
0.6948 |
Remote Similarity |
NPD7526 |
Approved |
0.6948 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD1398 |
Phase 1 |
0.6929 |
Remote Similarity |
NPD2231 |
Phase 2 |
0.6929 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6929 |
Remote Similarity |
NPD2235 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6923 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6886 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6883 |
Remote Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD9622 |
Approved |
0.6871 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6871 |
Remote Similarity |
NPD5735 |
Approved |
0.6866 |
Remote Similarity |
NPD7635 |
Approved |
0.6859 |
Remote Similarity |
NPD3687 |
Approved |
0.6859 |
Remote Similarity |
NPD3686 |
Approved |
0.6849 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6849 |
Remote Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD5588 |
Approved |
0.6846 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6846 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6842 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD5090 |
Approved |
0.6835 |
Remote Similarity |
NPD1778 |
Approved |
0.6835 |
Remote Similarity |
NPD5089 |
Approved |
0.6832 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6829 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD7095 |
Approved |
0.6825 |
Remote Similarity |
NPD288 |
Approved |
0.6818 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD2563 |
Approved |
0.6813 |
Remote Similarity |
NPD2560 |
Approved |
0.6803 |
Remote Similarity |
NPD1240 |
Approved |
0.6803 |
Remote Similarity |
NPD9295 |
Approved |
0.6803 |
Remote Similarity |
NPD943 |
Approved |
0.6802 |
Remote Similarity |
NPD7906 |
Approved |
0.68 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.68 |
Remote Similarity |
NPD6032 |
Approved |
0.6784 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6783 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6781 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6781 |
Remote Similarity |
NPD7985 |
Registered |
0.6776 |
Remote Similarity |
NPD4162 |
Approved |
0.6774 |
Remote Similarity |
NPD3158 |
Phase 1 |
0.6774 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD3157 |
Approved |
0.6768 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6767 |
Remote Similarity |
NPD556 |
Approved |
0.6763 |
Remote Similarity |
NPD5691 |
Approved |
0.6759 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.6755
|
Remote Similarity |
NPD6005 |
Phase 3 |